• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质纳米颗粒通过HITI介导的基因组编辑实现高效的体内DNA敲入。

Lipid Nanoparticles Enable Efficient In Vivo DNA Knock-In via HITI-Mediated Genome Editing.

作者信息

Hirose Jun, Aizawa Emi, Yamamoto Shogo, Xu Mingyao, Iwai Shigenori, Suzuki Keiichiro

机构信息

Graduate School of Engineering Science, Osaka University, Toyonaka 560-8531, Osaka, Japan.

Graduate School of Frontier Bioscience, Osaka University, Suita 565-0871, Osaka, Japan.

出版信息

Biomolecules. 2024 Dec 6;14(12):1558. doi: 10.3390/biom14121558.

DOI:10.3390/biom14121558
PMID:39766265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11673532/
Abstract

In vivo genome editing holds great therapeutic potential for treating monogenic diseases by enabling precise gene correction or addition. However, improving the efficiency of delivery systems remains a key challenge. In this study, we investigated the use of lipid nanoparticles (LNPs) for in vivo knock-in of ectopic DNA. Our in vitro experiments demonstrated that the homology-independent targeted integration (HITI)-mediated genome-editing method achieved significantly higher knock-in efficiency at the locus in hepatic cells compared to the traditional homology-directed repair (HDR)-mediated approach. By optimizing LNP composition and administration routes, we successfully achieved HITI-mediated GFP knock-in (2.1-2.7%) in the livers of mice through intravenous delivery of LNP-loaded genome editing components. Notably, repeated intravenous dosing led to a twofold increase in liver GFP knock-in efficiency (4.3-7.0%) compared to a single dose, highlighting the potential for cumulative genome editing effects. These findings provide a solid foundation for the use of LNPs in in vivo knock-in strategies, paving the way for future genome-editing therapies.

摘要

体内基因组编辑通过实现精确的基因校正或添加,在治疗单基因疾病方面具有巨大的治疗潜力。然而,提高递送系统的效率仍然是一个关键挑战。在本研究中,我们研究了脂质纳米颗粒(LNP)用于体内异位DNA敲入的情况。我们的体外实验表明,与传统的同源定向修复(HDR)介导的方法相比,同源性非依赖性靶向整合(HITI)介导的基因组编辑方法在肝细胞的位点实现了显著更高的敲入效率。通过优化LNP组成和给药途径,我们通过静脉注射负载LNP的基因组编辑组件,成功在小鼠肝脏中实现了HITI介导的GFP敲入(2.1 - 2.7%)。值得注意的是,与单次给药相比,重复静脉给药导致肝脏GFP敲入效率提高了两倍(4.3 - 7.0%),突出了累积基因组编辑效应的潜力。这些发现为LNP在体内敲入策略中的应用提供了坚实的基础,为未来的基因组编辑疗法铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/c63df5d53bd0/biomolecules-14-01558-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/93be130e2ca5/biomolecules-14-01558-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/bbf65addd53d/biomolecules-14-01558-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/e898a13afb9a/biomolecules-14-01558-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/e92482770d6d/biomolecules-14-01558-g0A4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/c5ab83e04d23/biomolecules-14-01558-g0A5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/66d7957246db/biomolecules-14-01558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/6bb005b185ee/biomolecules-14-01558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/7ed3bcf3de12/biomolecules-14-01558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/129ffb3302c2/biomolecules-14-01558-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/265dfa7b4194/biomolecules-14-01558-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/add44adc15c0/biomolecules-14-01558-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/7c0c759e91f0/biomolecules-14-01558-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/91157ef2e7af/biomolecules-14-01558-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/190731abf002/biomolecules-14-01558-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/0681d1f1711e/biomolecules-14-01558-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/c63df5d53bd0/biomolecules-14-01558-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/93be130e2ca5/biomolecules-14-01558-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/bbf65addd53d/biomolecules-14-01558-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/e898a13afb9a/biomolecules-14-01558-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/e92482770d6d/biomolecules-14-01558-g0A4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/c5ab83e04d23/biomolecules-14-01558-g0A5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/66d7957246db/biomolecules-14-01558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/6bb005b185ee/biomolecules-14-01558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/7ed3bcf3de12/biomolecules-14-01558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/129ffb3302c2/biomolecules-14-01558-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/265dfa7b4194/biomolecules-14-01558-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/add44adc15c0/biomolecules-14-01558-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/7c0c759e91f0/biomolecules-14-01558-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/91157ef2e7af/biomolecules-14-01558-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/190731abf002/biomolecules-14-01558-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/0681d1f1711e/biomolecules-14-01558-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc2/11673532/c63df5d53bd0/biomolecules-14-01558-g011.jpg

相似文献

1
Lipid Nanoparticles Enable Efficient In Vivo DNA Knock-In via HITI-Mediated Genome Editing.脂质纳米颗粒通过HITI介导的基因组编辑实现高效的体内DNA敲入。
Biomolecules. 2024 Dec 6;14(12):1558. doi: 10.3390/biom14121558.
2
Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.脂质纳米颗粒介导的 CRISPR-Cas9 RNP 与 mRNA/sgRNA 递送至体内外基因编辑的比较分析。
Eur J Pharm Biopharm. 2024 Mar;196:114207. doi: 10.1016/j.ejpb.2024.114207. Epub 2024 Feb 6.
3
Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.通过 CRISPR-Cas9 介导的非同源性靶向整合在人造血干/祖细胞中进行基因组编辑。
Mol Ther. 2021 Apr 7;29(4):1611-1624. doi: 10.1016/j.ymthe.2020.12.010. Epub 2020 Dec 10.
4
RNA lipid nanoparticles as efficient in vivo CRISPR-Cas9 gene editing tool for therapeutic target validation in glioblastoma cancer stem cells.RNA 脂质纳米颗粒作为有效的体内 CRISPR-Cas9 基因编辑工具,用于神经胶质瘤癌症干细胞中的治疗靶点验证。
J Control Release. 2024 Nov;375:776-787. doi: 10.1016/j.jconrel.2024.09.019. Epub 2024 Oct 2.
5
All-In-One Dendrimer-Based Lipid Nanoparticles Enable Precise HDR-Mediated Gene Editing In Vivo.基于树状聚合物的多功能脂质纳米粒实现精确 HDR 介导的体内基因编辑。
Adv Mater. 2021 Jul;33(30):e2006619. doi: 10.1002/adma.202006619. Epub 2021 Jun 17.
6
In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cells.经子宫内递送达靶可离子化脂质纳米颗粒促进了造血干细胞的体内基因编辑。
Proc Natl Acad Sci U S A. 2024 Aug 6;121(32):e2400783121. doi: 10.1073/pnas.2400783121. Epub 2024 Jul 30.
7
Glucocorticoid pre-administration improves LNP-mRNA mediated protein replacement and genome editing therapies.预先给予糖皮质激素可改善脂质纳米颗粒介导的蛋白质替代和基因组编辑疗法。
Int J Pharm. 2025 Mar 15;672:125282. doi: 10.1016/j.ijpharm.2025.125282. Epub 2025 Jan 27.
8
Transposase-CRISPR mediated targeted integration (TransCRISTI) in the human genome.转座酶-CRISPR 介导的靶向整合(TransCRISTI)在人类基因组中的应用。
Sci Rep. 2022 Mar 1;12(1):3390. doi: 10.1038/s41598-022-07158-8.
9
A biodegradable lipid nanoparticle delivers a Cas9 ribonucleoprotein for efficient and safe in situ genome editing in melanoma.一种可生物降解的脂质纳米颗粒递送Cas9核糖核蛋白,用于黑色素瘤中高效且安全的原位基因组编辑。
Acta Biomater. 2024 Dec;190:531-547. doi: 10.1016/j.actbio.2024.10.030. Epub 2024 Oct 25.
10
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing.单次给药的 CRISPR/Cas9 脂质纳米颗粒实现了体内基因组编辑的强大和持久效果。
Cell Rep. 2018 Feb 27;22(9):2227-2235. doi: 10.1016/j.celrep.2018.02.014.

引用本文的文献

1
Targeted in vivo gene integration of a secretion-enabled GLP-1 receptor agonist reverses diet-induced non-genetic obesity and pre-diabetes.具有分泌功能的胰高血糖素样肽-1受体激动剂的靶向体内基因整合可逆转饮食诱导的非遗传性肥胖和糖尿病前期状态。
Commun Med (Lond). 2025 Jul 9;5(1):269. doi: 10.1038/s43856-025-00959-8.

本文引用的文献

1
In vivo evaluation of guide-free Cas9-induced safety risks in a pig model.体内评估无导 Cas9 在猪模型中诱导的安全性风险。
Signal Transduct Target Ther. 2024 Jul 19;9(1):184. doi: 10.1038/s41392-024-01905-1.
2
Past, present, and future of CRISPR genome editing technologies.CRISPR 基因组编辑技术的过去、现在和未来。
Cell. 2024 Feb 29;187(5):1076-1100. doi: 10.1016/j.cell.2024.01.042.
3
Precise genome-editing in human diseases: mechanisms, strategies and applications.人类疾病中的精确基因组编辑:机制、策略和应用。
Signal Transduct Target Ther. 2024 Feb 26;9(1):47. doi: 10.1038/s41392-024-01750-2.
4
Recent advances in CRISPR-Cas9-based genome insertion technologies.基于CRISPR-Cas9的基因组插入技术的最新进展。
Mol Ther Nucleic Acids. 2024 Feb 5;35(1):102138. doi: 10.1016/j.omtn.2024.102138. eCollection 2024 Mar 12.
5
Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models.肺 SORT LNPs 可实现精确同源定向修复介导的囊性纤维化模型中的 CRISPR/Cas 基因组校正。
Nat Commun. 2023 Nov 11;14(1):7322. doi: 10.1038/s41467-023-42948-2.
6
genome editing using 244- LNPs and low-dose AAV achieves therapeutic threshold in hemophilia A mice.使用244-LNPs和低剂量腺相关病毒进行基因组编辑可在A型血友病小鼠中达到治疗阈值。
Mol Ther Nucleic Acids. 2023 Oct 7;34:102050. doi: 10.1016/j.omtn.2023.102050. eCollection 2023 Dec 12.
7
CRISPR-Cas9 homology-independent targeted integration of exons 1-19 restores full-length dystrophin in mice.CRISPR-Cas9介导的外显子1-19同源性无关的靶向整合可恢复小鼠体内的全长抗肌萎缩蛋白。
Mol Ther Methods Clin Dev. 2023 Aug 18;30:486-499. doi: 10.1016/j.omtm.2023.08.009. eCollection 2023 Sep 14.
8
Lipid Nanoparticle-Enabled Intracellular Delivery of Prime Editors.脂质纳米颗粒介导的 Prime 编辑器细胞内递送
AAPS J. 2023 Jun 28;25(4):65. doi: 10.1208/s12248-023-00833-2.
9
Lipid nanoparticle-based ribonucleoprotein delivery for in vivo genome editing.基于脂质纳米颗粒的核糖核蛋白递送来进行体内基因组编辑。
J Control Release. 2023 Mar;355:406-416. doi: 10.1016/j.jconrel.2023.02.008. Epub 2023 Feb 10.
10
Low-dose AAV-CRISPR-mediated liver-specific knock-in restored hemostasis in neonatal hemophilia B mice with subtle antibody response.低剂量 AAV-CRISPR 介导的肝特异性基因敲入可恢复具有轻微抗体反应的新生儿乙型血友病小鼠的止血功能。
Nat Commun. 2022 Nov 25;13(1):7275. doi: 10.1038/s41467-022-34898-y.